Complications of Axillary Lymph Node Dissection in Treatment of Early Breast Cancer: A Comparison of MRM and BCS

Indian Journal of Surgical Oncology

Volumn 2, Issue 2, 2011, Pages 126-132

  Brar, Preetinder ^a   Jain, Satish ^b   Singh, Iqbal ^a  

^a FORTIS HOSPITAL   (India)

^b Fortis Hospital ^*  (India)

Author keywords

Axillary lymph node dissection; Breast cancer; Complications; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; TAMOXIFEN;

ADJUVANT THERAPY; ADL DISABILITY; ADULT; AGED; ARM; ARM SWELLING; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL FEATURE; COMORBIDITY; COMPARATIVE EFFECTIVENESS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EARLY CANCER; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; GRAFT NECROSIS; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; JOINT LIMITATION; LIKERT SCALE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; MORBIDITY; PARESTHESIA; PARTIAL MASTECTOMY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; POSTOPERATIVE PAIN; PRIORITY JOURNAL; SELF REPORT; SHOULDER; WIDE EXCISION; WOUND INFECTION;

EID: 84873245516     PISSN: 09757651     EISSN: 09766952     Source Type: Journal    
DOI: 10.1007/s13193-011-0078-2     Document Type: Article

References (50)

1. Goel AK, Seenu V, Shukla NK, Raina V (1995) Breast Cancer presentation at a regional cancer centre. Natl Med J India 8: 6-9.
2. Moore MP, Kinne DW (1997) Axillary lymphadenopathy: a diagnostic and therapeutic procedure. J Surg Oncol 66: 2-6.
3. Nagel PHAF, Bruggink EDH, Wobbes Th, Strobbe LJA (2003) Arm morbidity after complete axillary lymph node dissection for breast cancer. Acta Chir Belg 103: 212-216.
4. Say CC, Donegan W (1979) A biostatical evaluation of complications from Mastectomy. Surg Gynaecological abstract 138: 370-376.
5. Aitken DR, Hinton JP (1983) Complications associated with mastectomy Surg Clin North Am 63: 1331-1352.
6. Budd DC, Cochran RC, Sturtz DL et al (1978) Surgical morbidity after mastectomy operations. Am J Surg 135: 218-220.
7. Kissin MW, Thompsone M, Price AB (1982) The inadequacy of axillary sampling in breast cancer. Lancet 29: 1210-1211.
8. Siegel BM, Mayzel MD, Love SM (1990) Level I and II axillary dissection in the treatment of early-stage breast cancer. Arch Surg 125: 1144-1147.
9. Rosen PP, Lesser ML, Kinne DW, Beattie E (1983) Discontinuous or "skip" metastases in breast carcinoma. Analysis of 1228 axillary dissections. Ann Surg 197: 276-283.
10. Veronesi U, Giovanni P, Galimberti V et al (1997) Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet 349: 1864-1867.
11. Petrek JA, Peters MM, Nori S et al (1990) Axillary lymphadenectomy. A prospective randomized trial of thirteen factors influencing drainage, including early and delayed arm mobilization. Arch Surg 125: 378-382.
12. Dauson I, Stain L, Heslinga JM et al (1989) Effect of shoulder immobilization on wound seroma and shoulder dysfunction following modified radical mastectomy. A randomized prospective clinical trial. Br J Surg 76: 311-312.
13. Jansen RFM, van Geel AN, de Groot HGW (1990) Immediate versus delayed shoulder exercises after axillary lymph node dissection. Am J Surg 160: 481-484.
14. Janni W, Rjosk D, Dimpfl TH, Haertl K, Storbl B, Hepp F et al (2001) Quality of life influenced by the primary surgical treatment for stage I-III breast cancer- long term follow up of a matched pair analysis. Ann Surg Oncol 8: 542-548.
15. Cohen L, Hack TF, de Moor C, Katz J, Goss PE (2000) The effects of type of surgery and time on the psychological adjustment in women after breast cancer treatment. Ann Surg Oncol 7: 427-434.
16. Dubashi B, Vidhubala E, Cyriac S, Sagar TG (2010) Quality of life among young women with breast cancer: study from a tertiary cancer institute in south India. Indian J of Cancer 47: 142-147, cited 2011 May 22.
17. Zarali O, Karman N, Ozaslan C, Huseyinova S, Altinok M (2009) Long term complications associated with mastectomy and axillary dissection. Acta Oncol Turcica 42: 17-23.
18. Zanapalioglu Y, Atahen K, Gur S, Cokmez A, Tarcan E (2009) Effect of breast conserving surgery in quality of life in breast cancer patients. J Br Health 5(3): 152-156.
19. Fisher B (2005) A vignette from breast cancer history: one hundred years after the Greenough report. J Am Bell Surg 2001(4): 484-486.
20. Fisher B, Redmond C, Wormark N (1989) Eight year results of randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in treatment of breast cancer. N Eng J Med 320(13): 822-828.
21. Sarrazin D, Le M, Rochard F (1989) Ten years results of randomized trial comparing a conservative treatment and mastectomy in early breast cancer. Radiother and Oncol 14: 177-184.
22. Veronesi U, Benfi A, Del Vecchio M et al (1998) Comparison of Halsted mastectomy with quadrantectomy, axillary dissection and radiotherapy in early breast cancer long term results. Eur J Cancer Clin Oncol 22: 1085-1089.
23. Fisher B, Redmond C, Fisher ER et al (1985) Ten year results of a randomized clinical trial comparing radical mastectomy and trial mastectomy with or without radiation. NEJM 312: 674-681.
24. Dewar JA, Sarrazin D et al (1987) Management of the axilla in conservatively treated breast cancer: 592 patients treated at Institute Gestave Roussy. Int J Radiot Oncol Biol Phys 13: 475-481.
25. Fisher B, Wormark N, Bauer M et al (1981) The accuracy of clinical nodal staging and of limited axillarydissection as a determinant of histological nodal status in carcinoma of the breast. Surg Gyn Obst 152: 765-772.
26. Fowble B, Solen L, Shultz D, Goodman R (1989) Frequency, sites of relapse and outcome of regional node failures following conservative surgery and radiation for early breast cancer. Int J Radiat Oncol Biol Phys 17: 703-710.
27. Gerard JP, Montbarbon JF et al (1985) Conservative treatment of early carcinoma of the breast: significance of axillary dissection and Iridium implant. Radiat Oncol 3: 17-22.
28. Leung S, Otmazguine Y et al (1986) Local regional recurrences following radical external beam irradiation and interstitial implantation for operable breast cancer - a 23 year experience. Radiat Oncol 5: 1-10.
29. Veronesi U, Paganelli G, Viale G et al (1999) Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst 91: 368-373.
30. Nandakumar A, Anantha N, Venugopal TC et al (1995) Survival in breast cancer: a population based study in Bangalore, India. Int J Cancer 60: 593-596.
31. Raina V, Bhutani M, Bedi R et al (2005) Clinical features and prognostic factors of early breast cancer at a major cancer centre in North India. Ind J Cancer 42: 40-45.
32. Pegorao RJ, Nirmal D, Bryer JV et al (1985) Clinical patterns of presentation of breast cancer of different racial group in South Africa. S Afr Med J 68: 808-810.
33. Bland KI, Vezerides MP et al (1999) Breast: principles of surgery, 533-601.
34. Kemperman H, Boyer J, Mar A et al (1995) Prognostic factors for survival after breast conserving therapy for stage I & II breast cancer. The role of local recurrence Aus J Cancer 31A: 690-698.
35. Mansfield CH, Kormarvicay LT et al (1995) Cancer 75: 2328-2336.
36. Jacobson JA, Danform DN et al (1995) Ten year results of a comparison of conservation with mastectomy in the treatment of stage I & II breast cancer. The New Eng J Med 332: 907-911.
37. Bland KI, Menck HR, Scott-Conner C et al (1998) The National Cancer Data base 10-year survey of breast carcinoma treatment at hospitals in the United States. Cancer 83: 1262-1273.
38. NHS Breast screening programme and British Association of Surgical Oncology Audit of Screen detected breast cancers. 1997-1998. NHS Breast screening Programme, 1999.
39. Deo SS, Mohanti BK et al (2001) Attitudes and treatment of breast conservation therapy for stage I & II breast cancer using per operative Iridium-192 implant boost to tumor bed. Australas Radiol 45: 35-58.
40. Biesterfield S, Schroder W et al (1979) Simultaneous histochemical and biochemical hormone receptor assessment in breast cancer provides complementary prognostic information. Aus Cancer Res 17: 4723-4729.
41. Li Cl, Doling JR, Maloni KE (2003) Incidence of invasive breast cancer by hormone receptor status from 1992 to 1998. J Clin Oncol 21: 28-34.
42. Raina V, Taneja V et al (2000) Estreogen receptor status in breast cancer. Indian Practitioner 53: 405-407.
43. Redkar AA, Kabre SS, Mittra I (1992) Estrogen and progesterone receptor measurement in breast cancer with enzyme immunoassay and Correlation with other prognostic factors. Indian J Med Res 96: 1-8.
44. Slamon D, Clark G, Woug S et al (1987) Human breast cancer: correlation of relapse and survival with amplification of the Her-2-neu oncogen. Science 235: 177-182.
45. Parmigiani G, Berry AD, Winer PE, Tebaldi C, Iglehart DJ, Prosnitz RL (1999) Is axillary lymph node dissection indicated for early-stage breast cancer? A Decision Analysis J Clin Oncol 17: 1465-1473.
46. Maunsell E, Brisson J, Deschenes L (1993) Arm problems and psychological distress after surgery for breast cancer. Can J Surg 36: 315-320.
47. Lin PP, Allison DC, Wainstock J et al (1993) Impact of axillary lymph node dissection on the therapy of breast cancer patients. J Clin Oncol 11: 1536-1544.
48. Ivens D, Hoe AL, Podd JJ et al (1992) Assessment of morbidity from complete axillary dissection. Br J Cancer 66: 136-138.
49. Warmuth MA, Brown G et al (1998) Complications of axillary lymph node dissection for carcinoma of the breast. A report based on patient survey. Cancer 83: 1362-1368.
50. Engel J, Kerr J, Schlesinger-Raab A, Sauer H, Hölzel D (2003) Axilla surgery severely affects quality of life: results of a 5-year prospective study in breast cancer patients. Breast Cancer Research and Treatment 79: 47-57.